Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patient...

por Sonnemann, Jürgen, Gänge, Jennifer, Pilz, Sabine, Stötzer, Christine, Ohlinger, Ralf, Belau, Antje, Lorenz, Gerd, Beck, James F
Publicado 2006

A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis

por Mahner, Sven, Oskay-Özcelik, Gülten, Heidrich-Lorsbach, Elke, Fuxius, Stefan, Sommer, Harald, Klare, Peter, Belau, Antje, Ruhmland, Birgit, Heuser, Thomas, Kölbl, Heinz, Markmann, Susanne, Sehouli, Jalid
Publicado 2012

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPA...

por Chekerov, Radoslav, Arndt, Tjadina, Pietzner, Klaus, Canzler, Ulrich, Wimberger, Pauline, Strauß, Hans-Georg, Mahner, Sven, Woelber, Linn, de Gregorio, Nikolaus, Stocker, Gertraud, von Abel, Ekkehard, Neunhoeffer, Tanja, Belau, Antje Kristina, Mustea, Alexander, Yalinkaya, Isil, Braicu, Elena Ioana, Richter, Rolf, Sehouli, Jalid
Publicado 2023

The Endocrine Treatment Landscape for Patients with HR+ HER2− Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy – A Real-World Analysis

por Nabieva, Naiba, Altmann, Falk, Apel, Klaus, Baerens, Dirk-Toralf, Beha, Michaela, Belau, Antje, Busch, Steffi, Guth, Dagmar, Heinrich, Georg, Kreiss-Sender, Janine, Markmann, Susanne, Olbermann, Andreas, Oskay-Özcelik, Gülten, Schuback, Beatrix, Steinfeld-Birg, Dieter, Quiering, Claudia, Kiss, Ferenc, Kreuzeder, Julia, Nuti, Paolo, Schilling, Jörg
Publicado 2023